Wetour Robotics ends $50M stock sale program

Wetour Robotics Ltd (WETO) reports the termination of its existing at-the-market equity offering program conducted under a Form F-3 shelf registration and related prospectus supplements.

Rhea-AI Filing Summary

Wetour Robotics Ltd (WETO) reports the termination of its existing at-the-market equity offering program conducted under a Form F-3 shelf registration and related prospectus supplements. The prior July 6, 2026 supplement covered offerings of Ordinary Shares of up to $50,000,000 under an At Market Sales Agreement with Chaince Securities, LLC.

Wetour Robotics states that since the July 6, 2026 prospectus supplement, it has offered and sold 25,606,595 Ordinary Shares for gross proceeds of approximately $2,290,279 pursuant to that Sales Agreement. On August 19, 2026, the company suspended sales, gave notice terminating the Sales Agreement and the related at-the-market offering, and is also terminating the related prospectuses, with these terminations becoming effective 5 calendar days after August 19, 2026.

Key Figures

ATM program capacity: $50,000,000 of Ordinary Shares Shares sold under ATM: 25,606,595 Ordinary Shares Gross proceeds from ATM sales: $2,290,279 +2 more

5 metrics

ATM program capacity $50,000,000 of Ordinary Shares Maximum amount covered by the July 6, 2026 prospectus supplement

Shares sold under ATM 25,606,595 Ordinary Shares Offered and sold since the July 6, 2026 prospectus supplement

Gross proceeds from ATM sales $2,290,279 Proceeds from 25,606,595 Ordinary Shares sold under the Sales Agreement

Termination notice date August 19, 2026 Date Wetour Robotics suspended sales and notified the sales agent of termination

Termination effective period 5 calendar days after August 19, 2026 Effective timing for termination of the Sales Agreement and related prospectuses

Key Terms

At Market Sales Agreement, at-the-market offering, prospectus supplement, Form F-3

4 terms

At Market Sales Agreement financial

"pursuant to the terms of that certain At Market Sales Agreement dated May 15, 2026"

at-the-market offering financial

"terminating the Sales Agreement and the “at-the-market” offering to which it relates"

An at-the-market offering is a method companies use to sell new shares of stock directly into the open market over time, rather than all at once. This allows them to raise money gradually, similar to selling small pieces of a product instead of a large batch. For investors, it means the company can access funding more flexibly, but it may also increase the supply of shares and influence the stock’s price.

prospectus supplement regulatory

"This prospectus supplement is not complete without, and may only be delivered"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

Form F-3 regulatory

"registration statement on Form F-3 (File No. 333-294373)"

Form F-3 is a U.S. securities filing that lets eligible foreign companies pre-register and then quickly sell shares or other securities to raise money, because they already meet ongoing reporting and size tests. For investors it signals that the company is up-to-date with regulatory disclosure and has an efficient way to issue new securities — similar to a pre-approved credit line — which can mean faster capital raises but also potential dilution of existing holdings.

Offering Details

ATM · Up to $50,000,000 of Ordinary Shares under prior July 6, 2026 supplement; program now terminated

Offering

Offering Type ATM

Securities Offered Ordinary Shares, par value $0.01 per share

Offering Amount Up to $50,000,000 of Ordinary Shares under prior July 6, 2026 supplement; program now terminated

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is Wetour Robotics (WETO) disclosing in this 424B5 prospectus supplement?

Wetour Robotics is disclosing that it has suspended sales under its at-the-market equity offering, is terminating the At Market Sales Agreement with Chaince Securities, LLC, and is terminating the related prospectuses, with termination effective 5 calendar days after August 19, 2026.

How much did Wetour Robotics (WETO) raise under the at-the-market program?

Since the July 6, 2026 prospectus supplement, Wetour Robotics sold 25,606,595 Ordinary Shares for gross proceeds of approximately $2,290,279 under the At Market Sales Agreement with Chaince Securities, LLC.

What was the maximum size of Wetour Robotics’ (WETO) at-the-market offering?

The July 6, 2026 prospectus supplement related to an at-the-market offering of Wetour Robotics’ Ordinary Shares for up to $50,000,000, conducted from time to time under a Form F-3 shelf registration and an At Market Sales Agreement with Chaince Securities, LLC.

When does the termination of Wetour Robotics’ (WETO) At Market Sales Agreement become effective?

Wetour Robotics states that termination of the At Market Sales Agreement and the related at-the-market offering, as well as termination of the related prospectuses, will be effective 5 calendar days after August 19, 2026, in accordance with the Sales Agreement.

Who acted as sales agent for Wetour Robotics’ (WETO) at-the-market offering?

Chaince Securities, LLC served as the sales agent for Wetour Robotics’ at-the-market offering pursuant to the At Market Sales Agreement dated May 15, 2026, as amended July 6, 2026.

Is Wetour Robotics (WETO) continuing to sell shares under the prior prospectuses?

No. Wetour Robotics suspended sales of Ordinary Shares on August 19, 2026 and is terminating both the At Market Sales Agreement and the related prospectuses, with termination effective 5 calendar days after that date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 05:00 PM EDT Accepted by SEC EDGAR 08/24/2026 - 05:00 PM EDT Learn about SEC filing dates

Filed Pursuant to Rule 424(b)(5)

Registration No. 333-294373

PROSPECTUS SUPPLEMENT

(To Prospectus dated March 30, 2026)

Wetour Robotics Limited

This prospectus supplement (“Prospectus Supplement”) amends and supplements the information in the prospectus, dated March 30, 2026, filed as a part of our registration statement on Form F-3 (File No. 333-294373), as supplemented by our prospectus supplements dated May 15, 2026 and July 6, 2026 (collectively, the “Prior Prospectuses”). This Prospectus Supplement should be read in conjunction with the Prior Prospectuses, and is qualified by reference thereto, except to the extent that the information herein amends or supersedes the information contained in the Prior Prospectuses. This prospectus supplement is not complete without, and may only be delivered or utilized in connection with, the Prior Prospectuses, and any future amendments or supplements thereto.

We filed the Prior Prospectuses to register the offer and sale of our ordinary shares, par value $0.01 per share (“Ordinary Shares”), from time to time pursuant to the terms of that certain At Market Sales Agreement dated May 15, 2026, as amended by the Amendment No.1 to the At Market Sales Agreement date July 6 2026 (the “Sales Agreement”), between Chaince Securities, LLC (the “Sales Agent”), acting as the agent, and us.

Since filing of the July 6, 2026 prospectus supplement for up to $50,000,000 Ordinary Shares, we have offered and sold 25,606,595 shares of Ordinary Shares for gross proceeds of approximately $2,290,279 pursuant to the Sales Agreement.

On August 19, 2026, we suspended sales of our Ordinary Shares pursuant to the Sales Agreement and provided notice to the Sales Agent that we are terminating the Sales Agreement and the “at-the-market” offering to which it relates, which termination will be effective 5 calendar days after August 19, 2026 in accordance with the terms of the Sales Agreement. We are filing this Prospectus Supplement to amend and supplement the information in the Prior Prospectuses to report the termination of the Sales Agreement and the “at-the-market” offering to which it relates and to terminate the Prior Prospectuses, which termination will be effective 5 calendar days after August 19, 2026 in accordance with the terms of the Sales Agreement.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying base prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

Chaince Securities, LLC

The date of this prospectus supplement is August 24, 2026